Comparing Angiomax to Heparin With Protamine Reversal in Patients OPCAB

Completed · Phase 3

Conditions studied: Cardiac Surgery, Coronary Artery Bypass Surgery

In brief

The purpose of this study is to examine the safety and efficacy of Angiomax as an alternative anticoagulant to heparin with protamine reversal in patients undergoing off-pump coronary artery bypass graft surgery.

Key facts

Study ID

NCT00073593

Run by

The Medicines Company

People needed

150

Starts

2003-08-01

Last updated by the study team

2011-11-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

Where it is running

• Cleveland Clinic Foundation — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.